<DOC>
	<DOCNO>NCT00929201</DOCNO>
	<brief_summary>This study demonstrate bioequivalence metformin single dose administration sitagliptin/metformin 50/500 mg fix dose combination ( FDC ) tablet concomitant administration single dose sitagliptin 50 mg metformin 500 mg individual tablet consumption high-fat meal .</brief_summary>
	<brief_title>Sitagliptin/Metformin Fed Bioequivalence Study ( 0431A-080 )</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<mesh_term>Sitagliptin Phosphate</mesh_term>
	<criteria>good health nonsmoker willing follow study guideline history illness condition might confound result study make participation unsafe participant nursing mother unwilling consume require highfat breakfast</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>July 2015</verification_date>
</DOC>